Experiment 199279

Worktypes

ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

ANNOSQUAMOSIN BKAURAN-19-OIC ACID,16-ALPHA-ENE: 17-HYDROXY:KAURAN-17-OIC ACID,19-FORMYL: ENT:KAURAN-19-AL,16-BETA-ENT: 17-HYDROXY:KAURAN-17-OIC ACID,19-NOR: 4-ALPHA-HYDROXY: ENT:CANDOL BKAURAN-19-OIC ACID,16-BETA-ENE: 17-ACETOXY:KAUR-16-EN-19-OIC ACID,ENT:KAURAN-19-OIC ACID,16-BETA-ENT: 17-HYDROXY:KAURAN-19-AL,16-BETA-17-DIHYDROXY: ENT:KAURANE-16-17-19-TRIOL,16-BETA: ENT:ANNOSQUAMOSIN AKAURAN-19-OIC ACID,16-ALPHA-17-DIHYDROXY:

Details

PropertyValue
Pharmacology
ANTIVIRAL ACTIVITY
OrganismAnnona squamosa (ANNONACEAE)
CitationWU,YC: HUNG,YC: CHANG,FR: COSENTINO,M: WANG,HK: LEE,KH:. (1996). IDENTIFICATION OF ENT-16-BETA, 17-DIHYDROXYKAURAN-19-OIC ACID AS AN ANTI-HIV PRINCIPLE AND ISOLATION OF THE NEW DITERPENOIDS ANNOSQUAMOSINS A AND B FROM ANNONA SQUAMOSA.. 59(6)
Amount utilized
Compound isolated
DiseaseASSAYED IN H9 LYMPHOCYTE CULTURES.
Number6
Qualitative resultINACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED